Cellular based immunotherapy for primary liver cancer

Cellular based immunotherapy for primary liver cancer

Abstract Primary liver cancer (PLC) is a common malignancy with high morbidity and mortality. Poor prognosis and easy recurrence on PLC patients calls for optimizations of the current conventional treatments and the exploration of novel therapeutic strategies. For most malignancies, including PLC, i...

Full description

Bibliographic Details
Main Authors: Yuanyuan Zheng, Yan Li, Jiao Feng, Jingjing Li, Jie Ji, Liwei Wu, Qiang Yu, Weiqi Dai, Jianye Wu, Yingqun Zhou, Chuanyong Guo
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Primary liver cancer
Cellular based immunotherapy
Lymphoid cell
Myeloid cell
Combined immunotherapy
Online Access:https://doi.org/10.1186/s13046-021-02030-5

Internet

https://doi.org/10.1186/s13046-021-02030-5

Similar Items